1. Home
  2. Share Market
  3. Stocks
  4. Alkem Laboratories
  5. Financial Statements
  6. ALKEM Quarterly Results

ALKEM Financial Statements

ALKEM Quarterly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 20 6.24 29.90 12.90
Op profit growth 5.69 31.80 43.30 2.95
EBIT growth 0.56 43.50 35 (2.80)
Net profit growth 3.82 40.60 78.60 (29)
Profitability ratios (%)        
OPM 19.30 21.90 17.70 16
EBIT margin 18 21.40 15.90 15.30
Net profit margin 15.50 17.90 13.50 9.82
RoCE 18 21.60 18.40 16.70
RoNW 5.14 5.85 5.11 3.38
RoA 3.87 4.50 3.92 2.69
Per share ratios ()        
EPS 141 135 96.10 53.40
Dividend per share 34 30 25 13
Cash EPS 112 110 73.10 40.80
Book value per share 722 617 515 407
Valuation ratios        
P/E 25.70 20.50 24.20 37
P/CEPS 32.20 25.30 31.80 48.40
P/B 5.01 4.49 4.52 4.86
EV/EBIDTA 19.60 15.10 18 21.40
Payout (%)        
Dividend payout -- -- -- 24.60
Tax payout (8.80) (12) (8.80) (31)
Liquidity ratios        
Debtor days 59.90 67 59.70 51
Inventory days 91.30 85 71.30 75.30
Creditor days (48) (53) (51) (58)
Leverage ratios        
Interest coverage (37) (32) (20) (18)
Net debt / equity 0.01 -- 0.08 0.09
Net debt / op. profit 0.04 (0.10) 0.36 0.41
Cost breakup ()        
Material costs (39) (39) (40) (39)
Employee costs (18) (18) (18) (19)
Other costs (23) (20) (24) (26)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 10,634 8,865 8,344 6,422
yoy growth (%) 20 6.24 29.90 12.90
Raw materials (4,180) (3,498) (3,345) (2,513)
As % of sales 39.30 39.50 40.10 39.10
Employee costs (1,963) (1,621) (1,505) (1,192)
As % of sales 18.50 18.30 18 18.60
Other costs (2,438) (1,803) (2,021) (1,689)
As % of sales 22.90 20.30 24.20 26.30
Operating profit 2,053 1,942 1,473 1,028
OPM 19.30 21.90 17.70 16
Depreciation (304) (275) (253) (143)
Interest expense (52) (59) (65) (55)
Other income 163 233 104 96
Profit before tax 1,859 1,842 1,260 926
Taxes (164) (224) (110) (288)
Tax rate (8.80) (12) (8.80) (31)
Minorities and other (35) (33) (22) (7.50)
Adj. profit 1,661 1,585 1,127 631
Exceptional items (15) -- -- --
Net profit 1,646 1,585 1,127 631
yoy growth (%) 3.82 40.60 78.60 (29)
NPM 15.50 17.90 13.50 9.82
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Profit before tax 1,859 1,842 1,260 926
Depreciation (304) (275) (253) (143)
Tax paid (164) (224) (110) (288)
Working capital 1,247 1,202 1,482 739
Other operating items -- -- -- --
Operating cashflow 2,638 2,545 2,378 1,235
Capital expenditure 417 162 1,003 627
Free cash flow 3,055 2,707 3,382 1,861
Equity raised 14,321 11,905 9,850 8,808
Investments 38.20 71.40 (183) (109)
Debt financing/disposal 3,088 2,139 1,509 883
Dividends paid -- -- -- 155
Other items -- -- -- --
Net in cash 20,502 16,822 14,557 11,599
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 23.90 23.90 23.90 23.90
Preference capital -- -- -- --
Reserves 8,614 7,353 6,137 5,415
Net worth 8,638 7,377 6,161 5,439
Minority interest
Debt 2,668 1,792 1,616 944
Deferred tax liabilities (net) 219 174 167 359
Total liabilities 11,734 9,524 8,092 6,875
Fixed assets 3,241 3,186 3,271 3,023
Intangible assets
Investments 371 333 261 324
Deferred tax asset (net) 1,528 1,282 1,100 1,066
Net working capital 4,015 2,733 2,367 1,800
Inventories 3,006 2,312 1,819 1,500
Inventory Days 103 95.20 79.60 --
Sundry debtors 1,885 1,607 1,649 1,248
Debtor days 64.70 66.20 72.10 --
Other current assets 1,679 982 920 744
Sundry creditors (1,173) (1,069) (954) (962)
Creditor days 40.30 44 41.70 --
Other current liabilities (1,380) (1,100) (1,067) (730)
Cash 2,579 1,990 1,092 662
Total assets 11,734 9,524 8,092 6,875
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2022 Mar-2022 Dec-2021 Sep-2021 Jun-2021
Gross Sales 2,576 2,484 2,619 2,800 2,731
Excise Duty -- -- -- -- --
Net Sales 2,576 2,484 2,619 2,800 2,731
Other Operating Income -- -- -- -- --
Other Income 51.40 20.50 53.50 42 46.70
Total Income 2,628 2,504 2,673 2,842 2,778
Total Expenditure ** 2,373 2,162 2,121 2,176 2,139
PBIDT 255 343 552 666 640
Interest 26.50 17 10.60 12 12.90
PBDT 228 326 541 654 627
Depreciation 76.30 83.10 77.50 72.80 70.50
Minority Interest Before NP -- -- -- -- --
Tax 34.90 43.40 92.20 108 118
Deferred Tax (14) 91.10 (162) (85) (42)
Reported Profit After Tax 131 108 533 559 480
Minority Interest After NP 3.81 0.63 7.69 14.30 12.10
Net Profit after Minority Interest 128 108 526 544 468
Extra-ordinary Items -- (6.70) -- -- --
Adjusted Profit After Extra-ordinary item 128 114 526 544 468
EPS (Unit Curr.) 10.70 9 44 45.50 39.20
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- 1,500 1,500 -- --
Equity 23.90 23.90 23.90 23.90 23.90
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 9.88 13.80 21.10 23.80 23.40
PBDTM(%) 8.86 13.10 20.70 23.40 22.90
PATM(%) 5.10 4.36 20.40 19.90 17.60

QuickLinks for Alkem Laboratories Ltd.

ALKEM Information

ALKEM Financials

ALKEM Results

ALKEM News

Open ZERO Brokerage Demat Account
Open Demat Account

  • ₹0

    Per Order for ETF & Mutual Funds Brokerage

  • ₹20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity